Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-19 Purchase |
2023-10-20 06:50 am |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO |
64,516 | $1.4025 | $90,484 | 132,516 (Direct) |
View |
| 2023-01-03 Purchase |
2023-01-05 5:08 pm |
Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director |
110,000 | $1.4165 | $155,815 | 174,000 (Direct) |
View |
| 2022-04-11 Purchase |
2022-04-13 4:05 pm |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
68,000 | $1.5 | $102,000 | 1,153,458 (Indirect Direct) |
View |
| 2021-06-02 Sale |
2021-06-03 5:40 pm |
Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
918,717 | $2.2737 | $2,088,857 | 3,637,314 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-23 Option Award(A) |
2024-11-05 5:00 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
90,909 | $0 | 660,909 (Indirect) |
View |
| 2024-09-23 Option Award |
2024-09-24 5:00 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
99,010 | $0 | 669,010 (Indirect) |
View |
| 2024-09-23 Option Award |
2024-09-24 5:00 pm |
N/A 2034-09-23 |
Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:30 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO |
263,960 | $0 | 2,281,934 (Indirect) |
View |
| 2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director |
61,676 | $0 | 61,676 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director |
61,676 | $0 | 61,676 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director |
61,676 | $0 | 61,676 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director |
61,676 | $0 | 61,676 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director |
61,676 | $0 | 61,676 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-15 4:46 pm |
N/A 2033-09-14 |
Protalix BioTherapeutics Inc. | PLX | Forster Eliot Director |
85,715 | $0 | 85,715 (Direct) |
View |
| 2023-08-15 Option Award |
2023-08-17 4:30 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
800,000 | $0 | 1,953,458 (Indirect) |
View |
| 2023-08-15 Option Award |
2023-08-17 4:30 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
201,903 | $0 | 570,000 (Indirect) |
View |
| 2023-08-15 Option Award |
2023-08-17 4:30 pm |
N/A 2033-08-15 |
Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development |
35,115 | $0 | 70,230 (Direct) |
View |
| 2023-08-15 Option Award |
2023-08-17 4:30 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations |
187,344 | $0 | 207,929 (Indirect) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:04 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:04 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations |
340,000 | $0 | 340,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:03 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:03 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:02 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
750,000 | $0 | 750,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:02 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:01 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Bronfeld Zeev Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:01 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:01 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 5:00 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 4:32 pm |
N/A 2032-06-30 |
Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-28 5:02 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
121,951 | $0 | 368,097 (Indirect) |
View |
| 2022-02-25 Option Award |
2022-02-28 5:01 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
637,531 | $0 | 1,085,458 (Indirect) |
View |
Ownership |
2021-02-16 12:07 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
0 | $0 | 7,372,932 (Direct) |
View |
| 2020-08-11 Option Award(A) |
2020-08-14 5:01 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
246,146 | $0 | 246,146 (Indirect) |
View |
| 2020-08-11 Option Award(A) |
2020-08-14 5:01 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
447,927 | $0 | 447,927 (Indirect) |
View |
| 2020-08-11 Option Award |
2020-08-13 5:03 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO |
246,146 | $0 | 246,146 (Indirect) |
View |
| 2020-08-11 Option Award |
2020-08-13 5:02 pm |
N/A N/A |
Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO |
447,927 | $0 | 447,927 (Indirect) |
View |
| 2020-08-11 Option Award |
2020-08-13 5:01 pm |
N/A 2030-08-11 |
Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations |
122,656 | $0 | 122,656 (Direct) |
View |
| 2020-07-05 Option Award |
2020-07-08 5:01 pm |
N/A 2030-07-05 |
Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development |
129,771 | $0 | 129,771 (Direct) |
View |